Extracellular Vesicles and Endothelial Function in Transgender Subjects
Launched by CENTRAL HOSPITAL, NANCY, FRANCE · Jul 12, 2021
Trial Information
Current as of June 27, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Trasgender subject demanding gender affirming hormonal therapy
- Exclusion Criteria:
- • Previous hormonal therapy
- • Pregnancy
- • Chronic disease
- • Cancer
- • Obesity
- • Drug abuse
- • Alcohol
- • Tabac
About Central Hospital, Nancy, France
Central Hospital, located in Nancy, France, is a leading healthcare institution dedicated to advancing medical research and improving patient outcomes. As a prominent clinical trial sponsor, the hospital is committed to conducting innovative studies across various therapeutic areas, fostering collaboration among multidisciplinary teams of healthcare professionals and researchers. With a strong emphasis on ethical standards and patient safety, Central Hospital leverages its state-of-the-art facilities and expertise to contribute to the development of cutting-edge treatments and enhance the overall quality of care within the community and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials